IMMUNOMEDICS
Summary
Immunomedics is a pharmaceutical company focusing on the development of antibody-drug conjugates for the treatment of cancer.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 16.78 B
Avg. Deal Size£ 8.39 B
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
